Hansoh Pharmaceutical (HKG:3692) said China's National Medical Products Administration accepted its application of olatorepatide injection to treat obesity, according to a Thursday filing with the Hong Kong bourse.
The drug is meant to be administered once a week.
Shares of the company fell nearly 1% in recent morning trade.
Qantas Airways' (ASX:QAN) market share trends in Australia overall remain stable at 49%, Jarden said in a Thursday note.Overall, the Australian market is expected to see a snap back in scheduled seats growth through July, up 11% year-over-year, driven largely by a scheduled uplift in seats capacity from Asian discounters and Chinese carriers.Deep capacity reductions for Middle East carriers, which fell 71% through April, but are set to recover over the course of the first half of fiscal year 2027, and restore capacity by June to pre-conflict levels. North American seat growth has remained resilient over the final few months of the second half of fiscal year 2026, based on current scheduled capacity.Based on Visible Alpha consensus estimates, Qantas' international capacity growth is forecast at 2.1% in the first half of fiscal year 2027.The investment firm retained its buy rating and its AU$11.25 per share price target on Qantas.
Fitch Ratings on Wednesday affirmed Li & Fung's long-term credit rating at "BB" after the Hong Kong-based logistics and supply chain company announced an agreement to acquire 55% of New Advent Global for about $250 million.The ratings agency also affirmed L&F's senior unsecured rating at "BB."Fitch said the rating was supported by the company's "unique position as a leading global sourcing and trading platform."The outlook on the rating was stable, reflecting the agency's expectation the acquisition will bolster L&F's business profile.
HFCL (NSE:HFCL, BOM:500183) approved a series of transactions to consolidate and expand its defense and aerospace business under HFCL Advance Systems or HASPL, a newly formed unit, according to a Wednesday filing to the Indian stock exchanges.The Indian telecom equipment maker will invest 892.5 million rupees in HASPL as part of a broader 1.75 billion-rupee funding round involving several investors. Upon completion, HFCL will hold a 51.02% stake in HASPL.The company also approved the sale of up to 80% of Raddef to HASPL for 750 million rupees and the transfer of its thermal weapon sight business to HASPL for 500 million rupees.Separately, HASPL approved the acquisition of HFCL Defence Systems from Defsys Solutions for 250 million rupees and will invest another 250 million rupees to acquire Defsys's aerostructure business.HFCL said the transactions will create an integrated defense platform spanning aerostructures, radar and surveillance systems, and thermal weapon sights, while providing access to an export order book of about 18.9 billion rupees.